Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
about
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteinsOncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsAdvanced cell therapies: targeting, tracking and actuation of cells with magnetic particlesImmunotherapeutic organoids: a new approach to cancer treatmentProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.Passive immunization against HIV/AIDS by antibody gene transfer.Development of adenoviral vector-based mucosal vaccine against influenza.In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line.A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGFGeneration of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.Novel adeno-associated viruses derived from pig tissues transduce most major organs in mice.The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particlesEpitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunityProtective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer.Helper-dependent adenoviral vectors for liver-directed gene therapy.Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.Implications of the innate immune response to adenovirus and adenoviral vectors.Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene deliveryHeterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.Inhibition of autophagy by 3-MA enhances IL-24-induced apoptosis in human oral squamous cell carcinoma cellsPEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion.Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors.Innate immune response to adenovirus.Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.Sequential expression of IGF-IB followed by active TGF-β1 induces synergistic pulmonary fibroproliferation in vivo.Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma.Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene deliverySelf-Assembly of a Multifunctional Lipid With Core-Shell Dendrimer DNA Nanoparticles Enhanced Efficient Gene Delivery at Low Charge Ratios into RPE Cells.Vectors for airway gene delivery.Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
P2860
Q24562788-96C9B6FE-22B4-45F1-BCD4-7E0A907EC9A1Q26776553-40E226E7-C41F-48FD-AC86-CB3638084214Q26782710-C5C2F0FE-51E4-48BB-890A-3C8BF58FF20AQ26853431-0DC9A521-CFF8-46A2-B320-CC8BE8D9F871Q30226988-800ECE1A-ED59-47F0-A2F7-666D17DAFB21Q30358434-144F0AD2-9F56-4622-A50F-386A1DF0A645Q30396642-85EAC761-5956-469F-9A3D-3E0C19CCFCE7Q33216908-6F703E1D-24B6-4024-BE09-055B2AFAE204Q33369214-E36DC450-4F23-4C23-BAD7-F70CE9D1DF40Q33586270-24CD962F-B21B-4925-AF89-0E0D8F3286FFQ33727055-24D74389-442D-4479-871B-8EC74103A9D1Q33792012-C67786E1-B25F-4E7C-92F6-9884D7C18779Q33881920-1BF87AF2-ACBD-455C-B15B-945DD0FDF3EDQ33906023-3525612E-3B9F-4E33-A191-298269C7A707Q33940167-502220E5-C957-4BE8-9250-A4685C3928C5Q33975595-B52BB0A7-F0D0-4C21-92C5-2B6EEB52623AQ34033557-DDA51360-0ADD-4995-8C8D-58D2422F3565Q34134316-956E9D07-31A7-45AF-B5D9-769F59334F9EQ34384998-F85B8D71-F50B-49C9-97A0-3E655975EB9EQ34415610-B7A3267C-0EFA-4AFB-A9CB-06FE66BF4DBBQ34648154-B8600FE1-1B00-4849-B7FD-E93CD5BC466FQ34701517-A101FC55-DCD4-43AD-97D6-545584A30CA6Q34717992-7E50BAE9-9314-478D-AF51-33D2825C8F7FQ34924696-A29FAB5B-6DDF-41B8-A828-3BA693A5CB39Q34982825-7310955E-C808-4FC2-9299-DC2D90DD8DFCQ34990401-7273788B-9A51-4987-9302-AB7FB1C63615Q35085363-920FA422-0FE4-408C-9E09-11303261A922Q35688220-7FCD4A78-15AB-4152-8AB9-6828B72E7315Q35889892-8BCCC0C8-8FF9-49EB-8442-35B75F1D721FQ36053858-429A4C13-C3E8-4C8D-90BE-A45B95BBD5CDQ36084329-C6B79D3E-5ACF-4A03-A52D-29A767F40BD4Q36085709-290EF6BB-3C23-49C7-A654-C5E4B320AEEFQ36278163-F1BA9D79-095F-4868-A107-572230C5CE55Q36315185-5AF5BDAD-D092-4368-97D7-287CE0C176C9Q36454392-04D2A23E-4EC6-4A51-9CE1-51CBCEBC473EQ36496709-F00E5E28-B8F1-4A09-AEE5-0E63DA58254CQ36616672-5C5F626A-62CE-4EC1-B254-E3048D199404Q36629672-B1EECC46-1F08-432A-9ADE-A16EFDD84B3EQ36780050-67E4ABC7-378B-40FE-9982-11FC2F305B29Q36873456-CB4C2CAB-3DED-47C6-A1FD-8720A7A9E6CE
P2860
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@ast
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@en
type
label
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@ast
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@en
prefLabel
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@ast
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@en
P2860
P356
P1433
P1476
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302037
P577
2003-06-01T00:00:00Z
P5875
P6179
1038063655